• Raimund Helbok, DaiWai M Olson, Peter D Le Roux, Paul Vespa, and Participants in the International Multidisciplinary Consensus Conference on Multimodality Monitoring.
• Department of Neurology, Neurocritical Care Unit, Innsbruck Medical University, Anichstr. 35, 6020, Innsbruck, Austria, raimund.helbok@uki.at.
• Neurocrit Care. 2014 Dec 1; 21 Suppl 2: S85-94.

AbstractThe effect of intracranial pressure (ICP) and the role of ICP monitoring are best studied in traumatic brain injury (TBI). However, a variety of acute neurologic illnesses e.g., subarachnoid hemorrhage, intracerebral hemorrhage, ischemic stroke, meningitis/encephalitis, and select metabolic disorders, e.g., liver failure and malignant, brain tumors can affect ICP. The purpose of this paper is to review the literature about ICP monitoring in conditions other than TBI and to provide recommendations how the technique may be used in patient management. A PubMed search between 1980 and September 2013 identified 989 articles; 225 of which were reviewed in detail. The technique used to monitor ICP in non-TBI conditions is similar to that used in TBI; however, indications for ICP monitoring often are intertwined with the presence of obstructive hydrocephalus and hence the use of ventricular catheters is more frequent. Increased ICP can adversely affect outcome, particularly when it fails to respond to treatment. However, patients with elevated ICP can still have favorable outcomes. Although the influence of ICP-based care on outcome in non-TBI conditions appears less robust than in TBI, monitoring ICP and cerebral perfusion pressure can play a role in guiding therapy in select patients.

42 keywords...

hide…